CLU and Alzheimer disease: A single intraperitoneal (i.p.)administration protected against neuronal death in the deep cerebellar nuclei [20], reduced the extra- and intracellular Aβ burden, and restored apoE and apoJ levels [21] in the 3xTg-AD mouse brain.